P1050: THROMBOCYTOPENIC MYELOFIBROSIS (MF) PATIENTS PREVIOUSLY TREATED WITH A JAK INHIBITOR IN A PHASE 3 RANDOMIZED STUDY OF MOMELOTINIB (MMB) VERSUS DANAZOL (DAN) [MOMENTUM]

por Vannucchi, A., Mesa, R., Gerds, A., Al-Ali, H. K., Lavie, D., Kuykendall, A., Grosicki, S., Iurlo, A., Goh, Y. T., Lazaroiu, M., Egyed, M., Fox, M. L., McLornan, D., Perkins, A., Yoon, S.-S., Gupta, V., Kiladjian, J.-J., Donahue, R., Kawashima, J., Verstovsek, S.
Publicado 2022